SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: Cheryl Galt who wrote (28918)6/23/1999 6:58:00 AM
From: Arthur Radley  Respond to of 32384
 
Would like to think there is a lot of merit to this evaluation of the stock. equities.barchart.com



To: Cheryl Galt who wrote (28918)6/23/1999 7:11:00 AM
From: Henry Niman  Respond to of 32384
 
The 26 Institution Study
cancernet.nci.nih.gov
is being headed by Harvard's Dana-Farber Cancer Center:

George Daniel Demetri, Principal Investigator, Ph: 617-632-3985
Dana-Farber Cancer Institute
Boston, Massachusetts, USA

I doubt that there is any problem with Advanced Breast Cancer patient accruals


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News